Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Aileen Chen, MD
CONTACT
Lead
M.D. Anderson Cancer Center
With
Primary Objectives: Phase I To evaluate the feasibility and safety of radiation therapy with NBTXR3 in LA-NSCLC with the following dose escalation: * 45 Gy in 15 fx with NBTXR3 at 22% RP2D * 52.5 Gy in 15 fx with NBTXR3 at 22% RP2D * 60 Gy in 15 fx with NBTXR3 at 22% RP2D * 60 Gy in 15 fx with NBTXR3 at 33% RP2D Phase II * To estimate the efficacy of radiation therapy alone with NBTXR3 in inoperable, locoregional NSCLC * To evaluate the safety of RP2D Secondary Objectives: * To evaluate the anti-tumor response of radiation with NBTXR3 in patients with inoperable, locoregional NSCLC * To evaluate time-to-event outcomes for radiation therapy with NBTXR3 in patients with inoperable, locoregional NSCL
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted